Health Care Utilization and Cost Burden of Herpes Zoster in a Community Population
Yawn, Barbara P., MD, MSc, Itzler, Robbin F., PhD, Wollan, Peter C., PhD, Pellissier, James M., PhD, Sy, Lina S., MPH, Saddier, Patricia, MD, PhD
Published in Mayo Clinic proceedings (01.09.2009)
Published in Mayo Clinic proceedings (01.09.2009)
Get full text
Journal Article
The potential cost-effectiveness of vaccination against herpes zoster and post-herpetic neuralgia
Brisson, Marc, Pellissier, James M., Camden, Stéphanie, Quach, Caroline, De Wals, Philippe
Published in Human vaccines (01.05.2008)
Published in Human vaccines (01.05.2008)
Get full text
Journal Article
Cost-effectiveness of Pembrolizumab as Second-line Therapy for the Treatment of Locally Advanced or Metastatic Urothelial Carcinoma in Sweden
Srivastava, Tushar, Prabhu, Vimalanand S., Li, Haojie, Xu, Ruifeng, Zarabi, Natalie, Zhong, Yichen, Pellissier, James M., Perini, Rodolfo F., de Wit, Ronald, Mamtani, Ronac
Published in European urology oncology (01.10.2020)
Published in European urology oncology (01.10.2020)
Get full text
Journal Article
Modeling the durability of ZOSTAVAX® vaccine efficacy in people ≥60 years of age
Li, Xiaoming, Zhang, Jane H, Betts, Robert F, Morrison, Vicki A, Xu, Ruifeng, Itzler, Robbin F, Acosta, Camilo J, Dasbach, Erik J, Pellissier, James M, Johnson, Gary R, Chan, Ivan S.F
Published in Vaccine (17.03.2015)
Published in Vaccine (17.03.2015)
Get full text
Journal Article
Incremental 1-Year Medical Resource Utilization and Costs for Patients with Herpes Zoster from a Set of US Health Plans
White, Ronald R., Lenhart, Greg, Singhal, Puneet K., Insinga, Ralph P., Itzler, Robbin F., Pellissier, James M., Segraves, Athur W.
Published in PharmacoEconomics (01.01.2009)
Published in PharmacoEconomics (01.01.2009)
Get full text
Journal Article
Comparative costs of ertapenem and cefotetan as prophylaxis for elective colorectal surgery
Wilson, Samuel E, Turpin, Robin S, Kumar, Ritesh N, Itani, Kamal M F, Jensen, Erin H, Pellissier, James M, Abramson, Murray A
Published in Surgical infections (01.06.2008)
Published in Surgical infections (01.06.2008)
Get more information
Journal Article
Incremental cost-effectiveness analysis comparing rofecoxib with nonselective NSAIDs in osteoarthritis : Ontario Ministry of Health perspective
MARSHALL, John K, PELLISSIER, James M, ATTARD, Cheryl L, KONG, Sheldon X, MARENTETTE, Michael A
Published in PharmacoEconomics (2001)
Published in PharmacoEconomics (2001)
Get full text
Journal Article
An observational, retrospective, cohort study of dosing patterns for rofecoxib and celecoxib in the treatment of arthritis
Schnitzer, Thomas J., Kong, Sheldon X., Mitchell, Jeffrey H., Mavros, Panagiotis, Watson, Douglas J., Pellissier, James M., Straus, Walter L.
Published in Clinical therapeutics (01.12.2003)
Published in Clinical therapeutics (01.12.2003)
Get full text
Journal Article
Cost-effectiveness of cyclooxygenase-2 inhibitors in chronic arthritis
Pellissier, James M, Watson, Douglas J, Kong, Sheldon X, Straus, Walter L
Published in Annals of internal medicine (04.05.2004)
Published in Annals of internal medicine (04.05.2004)
Get full text
Journal Article
Economic evaluation of a 2-dose hepatitis B vaccination regimen for adolescents
Levaux, H P, Schonfeld, W H, Pellissier, J M, Cassidy, W M, Sheriff, S K, Fitzsimon, C
Published in Pediatrics (Evanston) (01.08.2001)
Published in Pediatrics (Evanston) (01.08.2001)
Get more information
Journal Article
Modeling the durability of ZOSTAVAX registered vaccine efficacy in people greater than or equal to 60 years of age
Li, Xiaoming, Zhang, Jane H, Betts, Robert F, Morrison, Vicki A, Xu, Ruifeng, Itzler, Robbin F, Acosta, Camilo J, Dasbach, Erik J, Pellissier, James M, Johnson, Gary R, Chan, Ivan SF
Published in Vaccine (01.03.2015)
Published in Vaccine (01.03.2015)
Get full text
Journal Article